Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIMOGENE LAHERPAREPVEC vs TAMOXIFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALIMOGENE LAHERPAREPVEC vs TAMOXIFEN: Safety Overview

Metric TALIMOGENE LAHERPAREPVEC TAMOXIFEN
Total FAERS Reports 1,475 9,105
Deaths Reported 164 811
Death Rate 11.1% 8.9%
Hospitalizations 286 1,754
Average Patient Age 66.7 yrs 55.6 yrs
% Female Patients 48.3% 95.6%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Amgen Inc Dr. Reddy's Labratories Inc.
Route INTRALESIONAL ORAL
Marketing Status N/A Discontinued